Back to Search Start Over

Ibrutinib treatment in Waldenstrom's macroglobulinemia (WM): follow-up results of the phase 3 iNNOVATE (TM) study

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.dedup.wf.001..1b37eaa30365259c560f67a1253ca37a